Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Hope for women with Recurrent Miscarriage

  • Broadcast in Health
Powerful Patient

Powerful Patient


Follow This Show

If you liked this show, you should follow Powerful Patient.
Recurrent miscarriage is often a “silent epidemic” among women leading to depression and other issues. While there are many false misconceptions regarding pregnancy loss, recurrent miscarriage often is an indication of a chromosomal problem. There is hope for women with a new chromosomal testing called Comparative Genomic Hybridization (CGH). While there have been various different types of genetic testing available through infertility clinics to-date, researchers have been looking for screening methods that offer greater ability to determine the implantation potential for a single embryo. Early data suggests that CGH may be what we have been looking for as embryo implantation rates of up to 66% have been reported with this new testing. Dr. Carolyn Kaplan of the Georgia Reproductive Specialists speaks with Joyce about the problem of recurrent miscarriage and the technology of CGH.